ONCO (Onconetix, Inc.) חוב לטווח קצר להון

The price indicator on the Onconetix, Inc. (ONCO) chart reflects the financial standing of a business integrating environmental standards and bioethics into the development of anti-infective agents, while the individual debt-to-equity ratio stands at 0.01. Management is focused on bringing advanced solutions for urological and oncological profiles to market. Despite existing demand in diagnostics, limited operational scales render the company's current operational stability quite volatile.

This indicator compares the volume of liabilities maturing within one year to the market value of equity, determining the company's degree of dependence on emergency refinancing. For Onconetix, Inc. (ONCO), which lacks stable revenue and depends on grants, the short-term debt-to-equity ratio is critically important, as it demonstrates liquidity risk during the intervals between clinical trial phases.